Heterogenous nature of breast cancer is evident in the presence of multiple subtypes that are characterized based on the enrichment or absence of estrogen receptor (ER), progesterone receptor (PR) and/or human epidermal growth factor receptor 2 (HER2) expression [2]. This evidence concerns the gene ERBB2 and breast cancer.